down arrow

Kilitch Drugs

48
Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE729D01010
  • NSEID: KILITCH
  • BSEID: 524500
INR
331.50
-13.5 (-3.91%)
BSENSE

Apr 11, 12:51 PM

BSE+NSE Vol: 1.68 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Rs cr
Consolidated - Profit And Loss Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
No of Months
12
12
12
12
12
12
Operating Income
154.00
139.00
114.00
68.00
53.00
82.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
154.00
139.00
114.00
68.00
53.00
82.00
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
1.00
0.00
0.00
Raw Materials Consumed
79.00
74.00
65.00
36.00
29.00
48.00
Power & Fuel Cost
2.00
2.00
2.00
1.00
1.00
1.00
Employee Cost
10.00
11.00
6.00
5.00
5.00
5.00
Operating Expenses
4.00
4.00
5.00
5.00
4.00
3.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
-1.00
-1.00
Selling and Distribution Expenses
20.00
19.00
13.00
7.00
7.00
9.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
5.00
4.00
4.00
2.00
0.00
3.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
130.00
121.00
103.00
63.00
52.00
75.00
Operating Profit (PBDIT) excl Other Income
24.00
17.00
10.00
5.00
0.00
7.00
Other Income
4.00
2.00
2.00
2.00
4.00
4.00
Operating Profit (PBDIT)
28.00
20.00
13.00
7.00
4.00
11.00
Interest
6.00
5.00
1.00
0.00
0.00
0.00
Profit before Depriciation and Tax
22.00
15.00
12.00
7.00
3.00
10.00
Depreciation
3.00
3.00
2.00
1.00
1.00
2.00
Profit Before Taxation & Exceptional Items
19.00
12.00
9.00
5.00
1.00
8.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
19.00
12.00
9.00
5.00
1.00
8.00
Provision for Tax
5.00
3.00
3.00
1.00
0.00
4.00
Profit After Tax
13.00
8.00
6.00
3.00
0.00
3.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
69.00
59.00
51.00
48.00
48.00
45.00
Profit Available for appropriations
84.00
69.00
59.00
51.00
49.00
49.00
Appropriations
84.00
69.00
59.00
51.00
49.00
49.00
Equity Dividend (%)
0.00%
0.00%
0.00%
0.00%
0.00%
5.00%
Earnings Per Share
9.17
6.71
4.73
2.43
0.55
2.61
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2024 is 10.58% vs 22.20% in Mar 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2024 is 36.84% vs 68.83% in Mar 2023

stock-summary

Interest

YoY Growth in year ended Mar 2024 is 18.76% vs 281.89% in Mar 2023

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2024 is 63.90% vs 33.30% in Mar 2023

Compare Profit and Loss Results of Kilitch Drugs
Markets Mojo
Figures in Rs cr
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
154.00
10,334.00
-10,180.00
-98.51%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
154.00
10,334.00
-10,180.00
-98.51%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
-94.00
94.00
100.00%
Raw Materials Consumed
79.00
3,263.00
-3,184.00
-97.58%
Power & Fuel Cost
2.00
129.00
-127.00
-98.45%
Employee Cost
10.00
2,274.00
-2,264.00
-99.56%
Operating Expenses
4.00
210.00
-206.00
-98.10%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
20.00
928.00
-908.00
-97.84%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
5.00
134.00
-129.00
-96.27%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
130.00
7,798.00
-7,668.00
-98.33%
Operating Profit (PBDIT) excl Other Income
24.00
2,536.00
-2,512.00
-99.05%
Other Income
4.00
280.00
-276.00
-98.57%
Operating Profit (PBDIT)
28.00
2,817.00
-2,789.00
-99.01%
Interest
6.00
35.00
-29.00
-82.86%
Profit before Depriciation and Tax
22.00
2,782.00
-2,760.00
-99.21%
Depreciation
3.00
398.00
-395.00
-99.25%
Profit Before Taxation & Exceptional Items
19.00
2,384.00
-2,365.00
-99.20%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
19.00
2,399.00
-2,380.00
-99.21%
Provision for Tax
5.00
457.00
-452.00
-98.91%
Profit After Tax
13.00
1,926.00
-1,913.00
-99.33%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
69.00
8,012.00
-7,943.00
-99.14%
Profit Available for appropriations
84.00
9,925.00
-9,841.00
-99.15%
Appropriations
84.00
9,925.00
-9,841.00
-99.15%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
9.17
47.75
-38.58
-80.80%
Profit And Loss - Net Sales
Net Sales 154.37 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 10.58% vs 22.20% in Mar 2023

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 24.26 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 36.84% vs 68.83% in Mar 2023

Profit And Loss - Interest
Interest 6.04 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 18.76% vs 281.89% in Mar 2023

Profit And Loss - Profit After Tax
Profit After Tax 13.58 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 63.90% vs 33.30% in Mar 2023